NANOG and central nervous system cancer: TFP has been found to reduce the phenotype conversion of glioma cells into glioma initiating cells (GICs) by decreasing the radiation induced-Nanog expression, a pluripotency maintenance factor, and Glycogen synthase kinase-3 (GSK-3) activation.